Stockreport

Emmaus Life Sciences Announces Withdrawal of Marketing Authorization Application to European Medicines Agency

EMMAUS LIFE SCIENCES INC  (EMMA) 
PDF TORRANCE, Calif., Sept. 19, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in sickle cell disease treatment, today announced the withdrawal of its [Read more]